Skip to Main Content
Skip Nav Destination


Tranexamic Acid

Basics

Name

Tranexamic Acid

Pronunciation

(tran eks AM ik AS id)

Brand Names: US

  • Cyklokapron
  • Lysteda [DSC]

Therapeutic Category

  • Antifibrinolytic Agent
  • Antihemophilic Agent
  • Hemostatic Agent

Medication Safety Issues

Sound-alike/look-alike issues:

Cyklokapron may be confused with cycloSPORINE

High alert medication:

The Institute for Safe Medication Practices (ISMP) includes this medication among its list of drugs which have a heightened risk of causing significant patient harm when used in error (High-Alert Medications in Acute Care Settings).

Administration issues:

Inadvertent administration of tranexamic acid by the epidural or spinal route during neuraxial (eg, epidural, spinal) anesthesia has led to potentially fatal neurotoxic adverse reactions. Carefully evaluate storage procedures within the surgical suite, including separating tranexamic acid from local anesthetics; consider additional prevention measures, including purchasing, dispensing, and administration (ISMP [Smetzer] 2019; NAN Alert 2020; Patel 2019).

Other safety concerns:

TXA is an error-prone abbreviation (mistaken as TPA [tissue plasminogen activator])

This item requires a subscription. For full access to this content, please log in to an existing user account or purchase an individual subscription. If you have an active subscription and appear logged in (your name appears in the upper right corner), but you cannot access content, please click the “Log Out” option under your name and log back in.
Close Modal

or Create an Account

Close Modal
Close Modal